Understanding Response Metrics

A partial response in cancer treatment is defined as at least a 50% reduction in tumor diameter, with no new lesions or growth. The conversation highlights the grim reality of metastatic melanoma, where overall survival rates remain dismally low, particularly for patients who have already undergone high-dose interleukin two treatment. The shift in study focus to overall survival underscores the critical importance of this metric in evaluating treatment efficacy.